上海优宁维生物科技股份有限公司代理商

19

手机商铺

qrcode
商家活跃:
产品热度:
  • NaN
  • 0
  • 0
  • 2
  • 2
代理商

上海优宁维生物科技股份有限公司

入驻年限:19

  • 联系人:

    上海总部

  • 所在地区:

    上海 浦东新区

  • 业务范围:

    试剂

  • 经营模式:

    代理商

在线沟通

公司新闻/正文

【现货团购】BioXcell功能性抗体系列推荐-InVivoMAb anti-mouse PD-1 (CD279)

134 人阅读发布时间:2025-09-18 15:46

产品信息:
 - 纯度: >95%
 - 内毒素:<2EU/mg
 - 货号:BE0146
 - Clone: RMP1-14
新闻图片1

应用类型:
in vivo blocking of PD-1/PD-L signaling

参考文献:
1、"Reversal of indoleamine 2,3-dioxygenase-mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme" Nat Biotechnol 36(8): 758-764.
2、"The Antitumor Activity of Combinations of Cytotoxic Chemotherapy and Immune Checkpoint Inhibitors Is Model-Dependent" Front Immunol 9: 2100.
3、"Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses" Nat Med. doi : 10.1038/nm.4200.
4、"A Threshold Level of Intratumor CD8+ T-cell PD1 Expression Dictates Therapeutic Response to Anti-PD1" Cancer Res 75(18): 3800-3811.
5、"Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies" Cancer Immunol Res 3(6): 689-701.
6、"Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity" Cell 162(6): 1257-1270.
7、"PD-1 Co-inhibitory and OX40 Co-stimulatory Crosstalk Regulates Helper T Cell Differentiation and Anti-Plasmodium Humoral Immunity" Cell Host Microbe 17(5): 628-641
8、"Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer" Nature 520(7547): 373-377.
9、"TGFbeta Is a Master Regulator of Radiation Therapy-Induced Antitumor Immunity" Cancer Res 75(11): 2232-2242.

BioXcell功能性抗体(清除、阻断、中和)现货团购中,>50mg大包装爆款现货!

上一篇

【现货团购】BioXcell功能性抗体系列推荐-InVivoMAb anti-human PD-1 (CD279)

下一篇

【现货团购】BioXcell功能性抗体系列推荐-InVivoMAb anti-mouse PD-L1 (B7-H1)

更多资讯

我的询价